ABCB4 (MDR2) primarily functions as a:
ABCB4 designated MDR2/MDR3 in rodents and humans localizes to canalicular domain of hepatocytes and functions as phosphatidylcholine floppase, not as glucose transporter. Glucose symport is mediated by SLC5 family SGLT1 and SGLT2 which cotransport Na+ and glucose using sodium gradient rather than direct ATP hydrolysis, distinct from ABC primary pumps. ABCB4 mechanism follows canonical ABC cycle: ATP binding dimerizes nucleotide-binding domains, shifts transmembrane domains outward, flips phosphatidylcholine from cytosolic leaflet to lumenal leaflet where bile acids extract it into mixed micelles that buffer bile salt detergent activity and solubilize cholesterol. Loss-of-function produces toxic, phospholipid-depleted bile injuring biliary epithelium, causing progressive familial intrahepatic cholestasis type 3, gallstones, and pregnancy cholestasis. Accurate discrimination between secondary active SLC symporters for nutrients and primary ABC floppases for lipids is essential for understanding liver pathophysiology and correctly interpreting transporter classification in examinations. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.
Ref: Davit-Spraul et al., J Hepatol 2010, ABCB4 deficiency; Alberts, 7th ed., Chapter 11 flippases vs SLC.